| Item | Cat. No. | Application | Isotype |
| Anti-CA242 [WT 1-31](MABL-3891) | MABL-3891 | ELISA | Engineer antibody |
| Anti-CA50 [CA50Ab01](MABL-3892) | MABL-3892 | ELISA, IF | Engineer antibody |
| Anti-Canine Lymphoma [Mab231](MABL-3893) | MABL-3893 | RIA, FC | Engineer antibody |
| Anti-carcinoembryonic antigen (CEA) [Arcitumomab](MABL-3894) | MABL-3894 | IHC-P, FC, Imaging | Engineer antibody |
| Anti-carcinoembryonic antigen [A5B7](MABL-3895) | MABL-3895 | radiolabelling, therapeutic, IHC | Engineer antibody |
| Anti-CD155 [CD155.16 ](MABL-3896) | MABL-3896 | FC | Engineer antibody |
| Anti-CD155 [scFv1](MABL-3897) | MABL-3897 | IP, FC | Engineer antibody |
| Anti-CD155 [scFv3](MABL-3898) | MABL-3898 | functional assay | Engineer antibody |
| Anti-CD155 [SKII.4](MABL-3899) | MABL-3899 | ICC, IP, ELISA, FC, IF, IHC | Engineer antibody |
| Anti-CD19 [B4](MABL-3900) | MABL-3900 | FC, IF, IHC | Engineer antibody |
| Anti-CD30 [AC10 (Brentuximab)](MABL-3901) | MABL-3901 | functional assay, therapeutic, FC | Engineer antibody |
| Anti-CD30 [T105](MABL-3902) | MABL-3902 | in vitro, SPR, ELISA, FC | Engineer antibody |
| Anti-CD30 [T25](MABL-3903) | MABL-3903 | in vitro, SPR, ELISA, FC | Engineer antibody |
| Anti-CD30 [T408](MABL-3904) | MABL-3904 | in vitro, SPR, ELISA, FC | Engineer antibody |
| Anti-CD30 [T6](MABL-3905) | MABL-3905 | in vitro, SPR, ELISA, FC | Engineer antibody |
| Anti-CD9 [10E4](MABL-3906) | MABL-3906 | ELISA, FC | Engineer antibody |
| Anti-CD9 [Nb16-17](MABL-3907) | MABL-3907 | ELISA | Engineer antibody |
| Anti-CEA [BW431/26](MABL-3908) | MABL-3908 | Immunoscintigraphy | Engineer antibody |
| Anti-CEA [CH1A1A (2F1, CH1A1A-2F1)](MABL-3909) | MABL-3909 | ELISA, FC, IHC | Engineer antibody |
| Anti-CEA [EB-011](MABL-3910) | MABL-3910 | ELISA | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿(Mabioway)生物科技有限公司 版权所有
地址:陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话:15339069646 邮箱:info@mabioway.cn
